Pursuant to the terms of the agreement, SciGen will seek governmental approvals for the sale of Generex Oral-lyn in the territory using SciGen’s own recombinant human insulin product. SciGen will supply its recombinant human insulin and Generex will formulate and fill Generex Oral-lyn for marketing and distribution by SciGen in the territory.